2. Academic Validation
  3. AM-8553: a novel MDM2 inhibitor with a promising outlook for potential clinical development

AM-8553: a novel MDM2 inhibitor with a promising outlook for potential clinical development

  • J Med Chem. 2012 Jun 14;55(11):4934-5. doi: 10.1021/jm3007068.
Denzil Bernard 1,  Yujun Zhao,  Shaomeng Wang
Affiliations

Affiliation

  • 1 Department of Internal Medicine, University of Michigan Comprehensive Cancer Center, University of Michigan, Ann Arbor, Michigan 48109, United States.
PMID: 22624960 DOI: 10.1021/jm3007068
Figures
Products
  • Cat. No.
    Product Name
    Description
    Target
    Research Area
  • HY-18052
    MDM-2/p53 Inhibitor